top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in Cancer Treatment : From Systemic Chemotherapy to Targeted Therapy / / by Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares
Advances in Cancer Treatment : From Systemic Chemotherapy to Targeted Therapy / / by Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares
Autore Cavalcanti Iago Dillion Lima
Edizione [1st ed. 2021.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021
Descrizione fisica 1 online resource (VIII, 109 p. 27 illus., 25 illus. in color.)
Disciplina 616.994
Soggetto topico Oncology
Internal medicine
Pharmacy
Cancer—Treatment
Tumor markers
Cancer
Nanomedicine
Internal Medicine
Cancer Therapy
Tumour Biomarkers
Cancer Nanotechnology
Oncologia
Terapèutica
Fisiologia patològica
Nanomedicina
Soggetto genere / forma Llibres electrònics
ISBN 3-030-68334-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Introduction -- Cancer: concepts and epidemiology -- A brief history of cancer -- What is Cancer? -- Cancer Epidemiology -- Cancer development and immunology -- Cell cycle -- Cell cycle control: the function of cyclins -- Cancer triggering agents -- Proto-oncogenes -- Tumor suppressor genes -- Development of tumor mass -- Cancer Immunology -- Discovery of tumor markers -- Cancer diagnosis -- Impact of the discovery of tumor markers -- Main tumor markers for cancer diagnosis -- Alpha-fetoprotein (AFP) -- Human Chorionic Gonadotropin (β-HCG) -- Mucin-like cancer-associated antigen (MCA) -- CA 15.3 -- Carcinoembryonic antigen (CEA) -- Bladder tumor antigen (BTA) -- Telomerase -- Nuclear matrix protein (NMP 22) -- Cyfra 21.1 -- Prostatic acid phosphatase (PAP) -- Prostate-specific antigen (PSA) -- CA 125 -- CA 19.9 -- p53 -- CA 72.4 -- K-ras -- HER2 -- Cancer staging -- Conventional cancer treatment -- Therapeutic modalities of cancer -- Surgery -- Radiotherapy -- Antineoplastic chemotherapy -- Classification of antineoplastic agents by cycle -- Specific cycle antineoplastics -- Nonspecific antineoplastic agents -- Classification of antineoplastic agents by chemical structure and function -- Alkylating agents -- Antimetabolites -- Plant-derived antineoplastics -- Antitumor antibiotics -- Chemotherapy toxicity -- Hematological toxicity -- Liver toxicity -- Cardiac toxicity -- Anthracyclines -- Fluoropyrimidine -- Taxanes -- Pulmonary toxicity -- Neurological toxicity -- Renal toxicity -- Gastrointestinal toxicity -- Metabolic changes -- Targeted therapies in cancer treatment -- Overexpressed receptors on tumor cells -- Immunotherapy -- Monoclonal antibodies -- Types of monoclonal antibodies -- Side effects of monoclonal antibodies -- Checkpoint Inhibitors -- Side effects of checkpoint inhibitors -- Cancer Vaccines -- Vaccines in cancer prevention -- Vaccines for the treatment of cancer -- Non-specific immunotherapies -- Tyrosine kinase inhibitors -- Imatinib -- Gefitinib -- Erlotinib -- Sorafenib -- Dasatinib -- Nilotinib -- Lapatinib -- Adverse events of tyrosine kinase inhibitors -- Conventional chemotherapy vs. targeted therapy -- Differences between conventional chemotherapy and targeted therapy -- Risks and benefits of conventional chemotherapy compared to targeted therapy -- Eligibility criteria for the indication of the targeted therapy -- Side effects of targeted therapy -- Can targeted therapy replace conventional chemotherapy? -- Targeted therapy associated with conventional chemotherapy -- Pharmaceutical nanotechnology applied to cancer -- Pharmaceutical nanotechnology -- Classification of nanosystems -- Liposomes -- Micelles -- Polymeric nanoparticles -- Solid lipid nanoparticles -- Magnetic nanoparticles -- Metal nanoparticles -- Main functions of nanosystems in cancer -- Pharmaceutical nanotechnology in cancer diagnosis -- Pharmaceutical nanotechnology for cancer treatment.
Record Nr. UNINA-9910484989203321
Cavalcanti Iago Dillion Lima  
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Artificial Intelligence and Precision Oncology : Bridging Cancer Research and Clinical Decision Support / / edited by Zodwa Dlamini
Artificial Intelligence and Precision Oncology : Bridging Cancer Research and Clinical Decision Support / / edited by Zodwa Dlamini
Edizione [1st ed. 2023.]
Pubbl/distr/stampa Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023
Descrizione fisica 1 online resource (317 pages)
Disciplina 610.28563
Soggetto topico Cancer
Oncology
Medical screening
Cancer - Treatment
Tumor markers
Cancer Biology
Cancer Screening
Cancer Therapy
Tumour Biomarkers
Intel·ligència artificial en medicina
Oncologia
Soggetto genere / forma Llibres electrònics
ISBN 9783031215063
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1. Introduction: The Application of AI in Precision Oncology: Tailoring Diagnosis, Treatment, and the Monitoring of Disease Progression to the Patient -- Part I. Artificial Intelligence for Screening, Diagnosis, Monitoring in Precision Oncology -- Chapter 2. Application of AI in Novel Biomarkers Detection that Induce Drug Resistance, Enhance Treatment Regimens and Advancing Precision Oncology -- Chapter 3. Use of Artificial Intelligence in Implementing Mainstream Precision Medicine to Improve Traditional Symptom-driven Practice of Medicine: Allowing Early Interventions and Tailoring better-personalized Cancer Treatments -- Chapter 4. AI as a Novel Approach for Exploring ccfNAs in Personalized Clinical Diagnosis and Prognosis: Providing Insight into the Decision-Making in Precision Oncology -- Chapter 5. AI-Enhanced Digital Pathology and Radiogenomics in Precision Oncology -- Part II. Artificial Intelligence and Omics in Precision Oncology -- Chapter 6. Epigenetics Analysis Using Artificial Intelligence in the Era of Precision Oncology -- Chapter 7. Association of Metabolomics with AI in Precision Oncology: Emerging Perspectives for More Effective Cancer Care -- Chapter 8. Artificial Intelligence Application to Microbiomics Data for Improved Clinical Decision Making in Precision Oncology -- Part III. Artificial Intelligence in Cancer Therapy and the Clinical Applications -- Chapter 9. AI and Nanotechnology in Realizing the Goal of Precision Medicine: Tailoring the Best Treatment for Personalized Cancer Treatment -- Chapter 10. Artificial Intelligence-Based Medical Devices Revolution in Cancer Screening: Impact into Clinical Practice -- Chapter 11. Intelligent Drug Design and Use for Cancer Treatment: The Roles of AI and Precision Oncology in Targeting Patient-Specific Splicing Profiles -- Chapter 12. Applying Artificial Intelligence Prediction Tools for Advancing Precision Oncology in Immunotherapy: Future Perspectives in Personalized Care -- Chapter 13. Employing AI-Powered Decision Support Systems in Recommending the Most Effective Therapeutic Approaches for Individual Cancer Patients: Maximizing Therapeutic Efficacy -- Chapter 14. AI-Pathway Companion in Clinical Decision Support: Enabling Personalized and Standardized Care Along Care Pathways in Oncology -- Chapter 15. AI Tools Offering Cancer Clinical Applications for Risk Predictor, Early Detection, Diagnosis, and Accurate Prognosis: Perspectives in Personalised Care -- Chapter 16. Conclusion and Insights into the Future of AI in Precision Oncology.
Record Nr. UNINA-9910739486103321
Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biology of Bladder Cancer : From Molecular Insights to Clinical Strategies / / edited by Margaret A. Knowles, Lars Dyrskjøt
Biology of Bladder Cancer : From Molecular Insights to Clinical Strategies / / edited by Margaret A. Knowles, Lars Dyrskjøt
Autore Knowles Margaret A
Edizione [1st ed. 2024.]
Pubbl/distr/stampa Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024
Descrizione fisica 1 online resource (946 pages)
Disciplina 571.978
616.994
Altri autori (Persone) DyrskjøtLars
Collana Medicine Series
Soggetto topico Cancer
Oncology
Oncogenes
Tumor markers
Cancer - Treatment
Cancer Biology
Cancers
Tumour Biomarkers
Cancer Therapy
Càncer de bufeta
Soggetto genere / forma Llibres electrònics.
ISBN 9783031685057
3031685059
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Part I. Fundamentals of Bladder Cancer -- Chapter 1. Epidemiology of Bladder Cancer -- Chapter 2. Genetic Predisposition to Bladder Cancer -- Chapter 3. Human Urothelium -- Chapter 4. Bladder Cancer Pathology -- Chapter 5. Overview of Standard Therapy of Non Muscle-Invasive Bladder Cancer -- Chapter 6. Overview of Standard Therapy of Muscle-Invasive Bladder Cancer -- Part II. Molecular Genetics and Oncogenesis in Bladder Cancer -- Chapter 7. From Normalcy to Neoplasia: Mutational Events during Bladder Tumor Evolution -- Chapter 8. Cell Cycle Regulators as Oncogenic Drivers in Bladder Cancer -- Chapter 9. DNA Repair Pathway Alterations in Bladder Cancer -- Chapter 10. DNA Methylation and Chromatin Regulators in Bladder Cancer -- Part III. Pathogenesis and Microenvironment Dynamics in Bladder Cancer -- Chapter 11. Molecular Pathogenesis: Field Cancerization and Clonal Evolution in Urothelial Cancer Initiation and Progression -- Chapter 12. The Bladder Tumor Microenvironment -- Part IV. Molecular and Histological Subtypes of Bladder Cancer -- Chapter 13. Molecular Subtypes of Non-Muscle-Invasive Bladder Cancer -- Chapter 14. Molecular Subtypes of Muscle-Invasive Bladder Cancer -- Chapter 15. Molecular Features of Divergent Differentiation and Histological Subtypes in Bladder Cancer -- Part V. Experimental Models of Bladder Cancer -- Chapter 16. The Emerging Landscape of Mouse Bladder Cancer Models -- Chapter 17. In Vitro Bladder Cancer Models -- Part VI. Biomarkers for Diagnosis and Treatment of Bladder Cancer -- Chapter 18. Urine Biomarkers for Bladder Cancer Diagnosis and Screening -- Chapter 19. Blood-Based Biomarkers for Bladder Cancer Diagnosis and Prognosis -- Chapter 20. Mechanisms and Biomarkers of Response to BCG and Chemotherapy in Bladder Cancer -- Part VII. Therapeutic Application based on Molecular Insights -- Chapter 21. New Treatment Approaches in Non-Muscle-Invasive Bladder Cancer -- Chapter 22. New Treatment Approaches in Muscle-Invasive Bladder Cancer -- Chapter 23. Targeting the Immune Checkpoint in Bladder Cancer -- Part VIII. Future Directions in Bladder Cancer Research -- Chapter 24. Future Directions in Bladder Cancer Research and Clinical Implications.
Record Nr. UNINA-9910946349603321
Knowles Margaret A  
Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biomarkers and Biosensors for Cervical Cancer Diagnosis / / edited by John Bosco Balaguru Rayappan, Jung Heon Lee
Biomarkers and Biosensors for Cervical Cancer Diagnosis / / edited by John Bosco Balaguru Rayappan, Jung Heon Lee
Edizione [1st ed. 2021.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2021
Descrizione fisica 1 online resource (IX, 115 p. 18 illus., 15 illus. in color.)
Disciplina 610.28
Soggetto topico Cancer
Tumor markers
Medical screening
Materials
Detectors
Cancer Biology
Tumour Biomarkers
Cancer Screening
Sensors and biosensors
Càncer de coll uterí
Biosensors
Marcadors bioquímics
Diagnòstic
Soggetto genere / forma Llibres electrònics
ISBN 981-16-2586-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1. An Introduction to Cancer Biomarkers -- Chapter 2. Cervical Cancer -- Chapter 3. Potential Biomarkers for Early Diagnosis of Cervical Cancer -- Chapter 4. Methods for Screening of Cervical Cancer: State of Art -- Chapter 5. Electrochemical DNA Biosensors for Cervical Cancers -- Chapter 6. Optical DNA based Sensors for Cervical Cancers -- Chapter 7. Other Biosensors for Cervical Cancer Detection.
Record Nr. UNINA-9910495247203321
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Biomarkers in Diagnosis and Therapeutics / / edited by Adeeb Shehzad
Cancer Biomarkers in Diagnosis and Therapeutics / / edited by Adeeb Shehzad
Edizione [1st ed. 2022.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022
Descrizione fisica 1 online resource (372 pages)
Disciplina 616.994075
Collana Biomedical and Life Sciences Series
Soggetto topico Tumor markers
Cancer
Cancer - Treatment
Nanomedicine
Tumour Biomarkers
Cancer Biology
Cancer Therapy
Cancer Nanotechnology
Càncer
Marcadors bioquímics
Diagnòstic
Soggetto genere / forma Llibres electrònics
ISBN 981-16-5758-0
981-16-5759-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1. Introduction to cancer biomarkers -- Chapter 2.Technologies for identification and validation of cancer biomarkers -- Chapter 3. BIOMARKERS FOR CANCER DRUG DEVELOPMENT -- Chapter 4. Clinical proteomics: diagnostics and prognostic markers of Cancer -- Chapter 5.Microbiome as cancer biomarkers -- Chapter 6. Predictive biomarkers for anticancer drugs -- Chapter 7. Biomarkers in Cancer Survival and Drug Resistance -- Chapter 8. Biomarkers in tumor recurrence and metastasis -- Chapter 9. Biomarkers for Cancer Immunotherapy -- Chapter 10. Role of Biomarkers in Personalized Medicine -- Chapter 11.Development of Novel Cancer Biomarkers for Diagnosis and Prognosis -- Chapter 12. Nanotechnology for Cancer Biomarkers.
Record Nr. UNINA-9910743224703321
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Circulating Tumor Cells : Advances in Liquid Biopsy Technologies / / edited by Richard J. Cote, Evi Lianidou
Circulating Tumor Cells : Advances in Liquid Biopsy Technologies / / edited by Richard J. Cote, Evi Lianidou
Autore Cote Richard J
Edizione [2nd ed. 2023.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023
Descrizione fisica 1 online resource (672 pages)
Disciplina 616.994075
Altri autori (Persone) LianidouEvi
Collana Current Cancer Research
Soggetto topico Cancer
Cancer - Treatment
Tumor markers
Cancer Biology
Cancer Therapy
Tumour Biomarkers
ISBN 3-031-22903-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Part 1. CTC Technologies -- Affinity -- Physical -- ctDNA -- miRNA -- Exosomes -- Part 2 -- Biology of CTC -- Dormancy -- Culture -- EMT -- ctDNA and Exosomes -- Cells in circulation with CTC -- Part 3 -- CTC Analysis -- IHC, FISH, and other molecular assays -- Functional characterization -- Advanced microscopy and AI -- Analysis of non-cellular circulating markers -- Part 4 -- Clinical Applications of the Liquid Biopsy -- Early detection and cancer screening -- Prognosis and therapeutic monitoring -- Applications in Clinical Trials -- Applications in Drug Development.
Record Nr. UNINA-9910736978503321
Cote Richard J  
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Epigenetics of Cervical Cancer / / edited by Shama Prasada Kabekkodu, Aniruddha Chatterjee, Sanjiban Chakrabarty
Epigenetics of Cervical Cancer / / edited by Shama Prasada Kabekkodu, Aniruddha Chatterjee, Sanjiban Chakrabarty
Edizione [1st ed. 2025.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025
Descrizione fisica 1 online resource (XIII, 185 p. 17 illus., 16 illus. in color.)
Disciplina 572.865
Collana Biomedical and Life Sciences Series
Soggetto topico Epigenetics
Biochemical markers
Tumor markers
Cancer - Genetic aspects
Cancer
Medical screening
Cancer - Treatment
Biomarkers
Tumour Biomarkers
Cancer Genetics and Genomics
Cancer Screening
Cancer Therapy
ISBN 981-9639-85-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto -- Chapter 1: Introduction to Cervical Cancer -- Chapter 2: Epigenetic Mechanisms and Functions -- Chapter 3: HPV As an Inducer of Epigenetic Changes in Cervical Cancer -- Chapter 4: Microbiome and Epigenetic Interactions in Cervical Cancer -- Chapter 5: Role of DNA Methylation in Cervical Cancer -- Chapter 6: Chromatin Remodelling in Cervical Tumour Cells Regulates Proangiogenic Genes -- Chapter 7: Role of miRNAs in Cervical Cancer -- Chapter 8: Contribution of Long Noncoding RNAs and Other Noncoding RNAs in Cervical Cancer -- Chapter 9: Methods to Detect Epigenetic Changes -- Chapter 10:Role of Epigenetics in Cervical Cancer Radiotherapy Treatment Outcomes -- Chapter 11:Epigenetic Therapy in Cervical Cancer.
Record Nr. UNINA-9910996486603321
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunotherapy / / edited by Aung Naing, Joud Hajjar
Immunotherapy / / edited by Aung Naing, Joud Hajjar
Edizione [4th ed. 2021.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021
Descrizione fisica 1 online resource (445 pages)
Disciplina 616.079
Collana Advances in Experimental Medicine and Biology
Soggetto topico Immunotherapy
Cancer - Treatment
Tumors - Immunological aspects
Tumor markers
Cancer Therapy
Tumour Immunology
Tumour Biomarkers
ISBN 3-030-79308-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Immune System in Action -- 2. Resistance to Immunotherapy: Mechanisms and Means for Overcoming -- 3. Immunotherapy for Melanoma -- 4. Immunotherapy in Lung Cancer: Are the promises of long-term benefit finally met? -- 5. Landscape of Immunotherapy in Genitourinary Malignancies -- 6. Immuno-oncology for Gynecologic Malignancies -- 7. Immunotherapy for Neuro-oncology -- 8. Immunotherapy in Gastrointestinal Malignancies -- 9. An update on immune based therapies in acute myeloid leukemia: 2021 and beyond! -- 10. CAR T-cells -- 11. Skin Reactions to Immune Checkpoint Inhibitors -- 12. Immunotherapy Mediated luminal Gastrointestinal toxicities -- 13. Hepatobiliary and Pancreatic Adverse Events -- 14. Pulmonary toxicities of immunotherapy -- 15. Immune checkpoint inhibitors (ICIs) related cardiotoxicity -- 16. Renal Toxicity -- 17. Immune-Related Oral, Otologic and Ocular Adverse Events -- 18. Neurologic Toxicities of Immunotherapy -- 19. Cancer Imaging in Immunotherapy. .
Record Nr. UNINA-9910520092303321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Machine Learning for Advanced Functional Materials / / edited by Nirav Joshi, Vinod Kushvaha, Priyanka Madhushri
Machine Learning for Advanced Functional Materials / / edited by Nirav Joshi, Vinod Kushvaha, Priyanka Madhushri
Autore Joshi Nirav
Edizione [1st ed. 2023.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023
Descrizione fisica 1 online resource (306 pages)
Disciplina 620.110285631
Altri autori (Persone) KushvahaVinod
MadhushriPriyanka
Collana Physics and Astronomy Series
Soggetto topico Optics
Machine learning
Materials
Detectors
Tumor markers
Photonics
Optical engineering
Optics and Photonics
Machine Learning
Sensors and biosensors
Tumour Biomarkers
Photonics and Optical Engineering
Photonic Devices
ISBN 981-9903-93-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Solar Cells and Relevant Machine Learning -- Machine learning-driven gas identification in gas sensors -- Recent advances in Machine Learning for electrochemical, optical, and gas sensors -- Machine Learning in Wearable Healthcare Devices -- A Machine Learning approach in wearable Technologies -- The application of novel functional materials to machine learning -- Potential of Machine Learning Algorithms in Material Science: Predictions in design, properties and applications of novel functional materials -- Perovskite Based Materials for Photovoltaic Applications: A Machine Learning Approach -- A review of the high-performance gas sensors using machine learning -- Machine Learning For Next‐Generation Functional Materials -- Contemplation of Photocatalysis Through Machine Learning -- Discovery of Novel Photocatalysts using Machine Learning Approach -- Machine Learning In Impedance Based Sensors.
Record Nr. UNINA-9910726286403321
Joshi Nirav  
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Biomarkers for Cancer Diagnosis and Therapy / / edited by Ranbir Chander Sobti, Haruhiko Sugimura, Aastha Sobti
Molecular Biomarkers for Cancer Diagnosis and Therapy / / edited by Ranbir Chander Sobti, Haruhiko Sugimura, Aastha Sobti
Edizione [1st ed. 2024.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024
Descrizione fisica 1 online resource (770 pages)
Disciplina 616.994075
Soggetto topico Cancer
Tumor markers
Cancer - Treatment
Cancer - Genetic aspects
Cancer Biology
Tumour Biomarkers
Cancer Therapy
Cancer Genetics and Genomics
Marcadors tumorals
Soggetto genere / forma Llibres electrònics
ISBN 9789819937462
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1. Molecular Biomarkers of Cancer and their Diagnostic Applications -- Chapter 2. Statistical Models in Cancer Management -- Chapter 3. Deep Learning Techniques for Computer Aided Diagnosis of Various Cancers -- Chapter 4. Machine Learning Techniques in Computer Aided Diagnosis for Effective Detection of Malignant Tissues -- Chapter 5. Molecular Mechanisms of Oncogenesis -- Chapter 6. Application of CRISPR in Cancer Research and Treatment -- Chapter 7. Nanobiosensing Platforms for Early Detection of Cancer -- Chapter 8. Bionanotechnological Strategies and Tools for Cancer Prediction, Prevention and Therapy -- Chapter 9. Central Nervous System Tumors -- Chapter 10. Biomedical Approaches in the Research and Management of Head and Neck Squamous Cell Carcinoma -- Chapter 11. Applications of Molecular Biology and Biomedical Advances in Ocular Oncology -- Chapter 12. Molecular Markers in Oral Cancer -- Chapter 13. MicroRNAs as Tools for Early Diagnosis and Predicting Response to Therapy in Oesophageal Cancer -- Chapter 14. The Role of Complement Regulatory Proteins during Liver Homeostasis and Hepatitis C Virus-related Liver Disease -- Chapter 15. Metabolite based Biosignature of Pancreatic Cancer -- Chapter 16. Molecular Pathogenesis of Lung Cancer: Evolving Landscape based on Past Experience -- Chapter 17. Molecular Insights and Risk Factors Associated with Small and Non-Small Cell Lung Cancer -- Chapter 18. Deciphering the Role of Immune-Checkpoint Inhibitors in Lung Cancer Treatment -- Chapter 19. Bone Tumors: An Overview -- Chapter 20. Genomics in the ‘Personalize’ Management of Breast Cancer -- Chapter 21. Colorectal Cancer and Role of Biomarkers in Diagnosis, Prognostification and Personalized Treatment -- Chapter 22. Biomarkers in Renal Cell Carcinoma -- Chapter 23. Androgen and Estrogen Signalling Pathways in Prostate Hyperplastic Tissues: Opportunities for Therapeutic Targeting from Multiple Angles -- Chapter 24. Role of Circadian Rhythm in Hormonal Cancers -- Chapter 25. Recent Immunotherapeutic Approaches for Cancer Treatment -- Chapter 26. Importance of Adme for Anticancer Prodrugs -- Chapter 27. Personalized Medicine in Clinical Management of Breast Cancer - Where Do We Stand? -- Chapter 28. PABPC1: A Novel Emerging Target for Cancer Prognostics and Anti-Cancer Therapeutics -- Chapter 29. Recent Update on Pyridoxine Derivatives as Anticancer Agents with Overview on its Patents -- Chapter 30. Recent Advances in Iron Oxide Nanoparticles-based Nano Medicine for Prostate Cancer: A Review -- Chapter 31. Therapeutic Applications of Snake Venom Proteins as Anti-Cancer Agents -- Chapter 32. Revamping Anticancer Strategies by Modulating Tumor Microenvironment using Botanicals -- Chapter 33. Modulation of Epigenetic Regulators for Cancer Prevention by Dietary Phytochemicals: Tools for Personalized Nutrition.
Record Nr. UNINA-9910869175103321
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui